BMO Capital Initiates Coverage On Tenet Healthcare with Market Perform Rating, Announces Price Target of $265
Benzinga Newsdesk 1 month ago
Analyst RatingsNewsInitiationPrice Target
BMO Capital analyst Sean Dodge initiates coverage on Tenet Healthcare (NYSE:THC) with a Market Perform rating and announces Price Target of $265.
BMO Capital analyst Sean Dodge initiates coverage on Tenet Healthcare (NYSE:THC) with a Market Perform rating and announces Price Target of $265.